Similar to This
Beyond statins, one drug lowered heart attack risk by 20%
Beyond statins, one drug lowered heart attack risk by 20%: A new study could help doctors figure out what medicine to prescribe for cholesterol when statins ...
statnews.com/2026/11/05/repatha-vs-zetia-cholesterol-study-heart-attack-risk/
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides: The Department of Health and Human Services will let small compounding pharmacies make six ...
npr.org/2026/10/28/nx-s1-6021030/peptides-compounding-enforcement
Why Big Pharma is betting on longevity drugs
Why Big Pharma is betting on longevity drugs: Inside the conference where FDA officials, Eli Lilly, Pfizer, and biotech leaders mapped out the future of ...
businessinsider.com/why-big-pharma-betting-longevity-drugs-2026-10
Medicine shortages grow in Iran as US tightens sanctions, blockade
Medicine shortages grow in Iran as US tightens sanctions, blockade: Many Iranians cannot access or afford life-saving drugs, but authorities say pharmaceutical ...
aljazeera.com/news/2026/9/9/medicine-shortages-grow-in-iran-as-us-tightens-sanctions-blockade
The FDA removed the red tape around one of the best drugs for children ...
The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains
statnews.com/2026/09/04/clozapine-children-schizophrenia-neutrophil-fda-monitoring/
Argenx Breaks Out On Another Multibillion-Dollar Opportunity For Vyvgart
Argenx Breaks Out On Another Multibillion-Dollar Opportunity For Vyvgart: Argenx stock surged Monday after its blockbuster autoimmune drug, Vyvgart ...
investors.com/news/technology/argenx-stock-vyvgart-imnm-dm-treatment/
California Supreme Court sides with Gilead in ‘duty’ to innovate case
California Supreme Court sides with Gilead in ‘duty’ to innovate case: Advocates argued Gilead was negligent for slow-walking development of an HIV medicine that ...
statnews.com/pharmalot/2026/08/03/california-supreme-court-sides-with-gilead-in-duty-to-innovate-case/
We’re beating heart disease
We’re beating heart disease: The FDA-approved pill enlicitide lowers LDL cholesterol by nearly 60 percent, marking the latest advance in medicine’s decades-long ...
vox.com/future-perfect/496672/heart-disease-cholesterol-ldl-death-health
Pharmalittle: We’re reading about a U.S. peptide panel’s votes ...
Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
statnews.com/pharmalot/2026/07/27/fda-panel-peptide-votes-amgen-fights-tavneos-withdrawal/
Amgen Drug Gets New Warnings in Japan After Patient Deaths
Amgen Drug Gets New Warnings in Japan After Patient Deaths: Japanese drugmaker that sells rare-disease medicine Tavneos says new patients will be able to get the ...
wsj.com/health/pharma/amgen-drug-gets-new-warnings-in-japan-after-patient-deaths-e903b551
FDA approves Denali Therapeutics drug for Hunter syndrome
FDA approves Denali Therapeutics drug for Hunter syndrome: The decision is notable in part because it follows a string of FDA rejections or calls for additional ...
statnews.com/2026/03/25/denali-therapeutics-hunter-syndrome-rare-disease/